
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Microbiol. , 25 October 2021
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 12 - 2021 | https://doi.org/10.3389/fmicb.2021.736304
A retraction of this article was approved in:
Retraction: vB-ApyS-JF1, the first Trueperella pyogenes phage, shows potential as an alternative treatment strategy for Trueperella pyogenes infections
Citation: Ji Y, Song L, Zhou Z, Liu X, Li F, Guo Z, Guan Y, Yang L, Feng X, Sun C, Lei L, Han W and Gu J (2021) vB-ApyS-JF1, the First Trueperella pyogenes Phage, Shows Potential as an Alternative Treatment Strategy for Trueperella pyogenes Infections. Front. Microbiol. 12:736304. doi: 10.3389/fmicb.2021.736304
Received: 07 July 2021; Accepted: 21 September 2021;
Published: 25 October 2021; Retracted: 01 December 2023.
Edited by:
You-Hee Cho, CHA University, South KoreaReviewed by:
Kelei Zhao, Chengdu University, ChinaDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.